{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-018632","form_type":"8-K","ticker":"NEPH","cik":"0001196298","company_name":"NEPHROS INC","filed_at":"2022-07-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.150308+00:00","generated_at":"2026-06-24T20:30:07.261208+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Nephros prelim Q2 revenue $2.9M, up 27% YoY; expects positive net cash flow in 12 months","bullets":["Q2 2022 preliminary net revenue ~$2.9M, a 27% increase from $2.3M in Q2 2021.","Active customer sites grew 21% YoY to 1,349, adding 232 sites in trailing 12 months.","Expense management plan includes headcount reductions and facility consolidations; company projects positive net cash flow within 12 months.","Ended Q2 with approximately $4.2M in cash on a consolidated basis."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-018632","json":"https://secwatch.observer/filing/0001493152-22-018632.json","markdown":"https://secwatch.observer/filing/0001493152-22-018632.md","text":"https://secwatch.observer/filing/0001493152-22-018632.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1196298/000149315222018632/0001493152-22-018632-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1196298/000149315222018632/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T20:30:07.261208+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}